FlexShares Credit-Scored US Long Corporate Bond Index Fund (LKOR)
| Assets | $36.33M |
| Expense Ratio | 0.15% |
| PE Ratio | n/a |
| Shares Out | 1.15M |
| Dividend (ttm) | $2.36 |
| Dividend Yield | 5.55% |
| Ex-Dividend Date | Dec 19, 2025 |
| Payout Frequency | Monthly |
| Payout Ratio | n/a |
| Volume | 1,962 |
| Open | 42.66 |
| Previous Close | 42.75 |
| Day's Range | 42.59 - 42.71 |
| 52-Week Low | 39.49 |
| 52-Week High | 44.34 |
| Beta | 0.68 |
| Holdings | 776 |
| Inception Date | Sep 24, 2015 |
About LKOR
Fund Home PageThe FlexShares Credit-Scored US Long Corporate Bond Index Fund (LKOR) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks an index of USD-denominated investment grade corporate bonds with at least 10 years to maturity selected and weighted by fundamental factors. LKOR was launched on Sep 24, 2015 and is issued by FlexShares.
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 19, 2025 | $0.20433 | Dec 26, 2025 |
| Dec 1, 2025 | $0.1858 | Dec 5, 2025 |
| Nov 3, 2025 | $0.18402 | Nov 7, 2025 |
| Oct 1, 2025 | $0.18591 | Oct 7, 2025 |
| Sep 2, 2025 | $0.17378 | Sep 8, 2025 |
| Aug 1, 2025 | $0.20215 | Aug 7, 2025 |
Performance
LKOR had a total return of 6.62% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.28%.
News
What's Going On With Treasury Rates?
We think the Fed has time to assess the impact of tariffs, and we expect it to wait to cut rates until the data show that tariffs are impacting the real economy. So far, there are no signs of recessio...
The Credit Opportunity In M&A
M&A was almost dormant in 2023. In the US, as a proportion of the market value of the benchmark equity indices, it fell to its lowest level in 20 years, according to McKinsey. Credit investors are not...
Best Investment Grade Corporate Bond ETFs for Q1 2020
The best Investment Grade Corporate Bond ETFs for Q1 2020 are LKOR, SPLB, and VCLT.
Top 5 Bond ETFs for 2018
Five bond ETFs with top returns and interest rate considerations for 2018.